215 related articles for article (PubMed ID: 21122558)
1. A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine.
Gerich ME; Quiros JA; Marcin JP; Tennyson L; Henthorn M; Prindiville TP
J Crohns Colitis; 2010 Nov; 4(5):546-52. PubMed ID: 21122558
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
3. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
[TBL] [Abstract][Full Text] [Related]
4. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.
Shih DQ; Nguyen M; Zheng L; Ibanez P; Mei L; Kwan LY; Bradford K; Ting C; Targan SR; Vasiliauskas EA
Aliment Pharmacol Ther; 2012 Sep; 36(5):449-58. PubMed ID: 22784257
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
[TBL] [Abstract][Full Text] [Related]
6. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
[TBL] [Abstract][Full Text] [Related]
7. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Brackett J; Schafer ES; Leung DH; Bernhardt MB
Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
[TBL] [Abstract][Full Text] [Related]
8. Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease.
Pozler O; Chládek J; Malý J; Hroch M; Dědek P; Beránek M; Krásničanová P
J Crohns Colitis; 2010 Dec; 4(6):623-8. PubMed ID: 21122571
[TBL] [Abstract][Full Text] [Related]
9. Utility of measuring 6-methylmercaptopurine and 6-thioguanine nucleotide levels in managing inflammatory bowel disease patients treated with 6-mercaptopurine in a clinical practice setting.
Mardini HE; Arnold GL
J Clin Gastroenterol; 2003; 36(5):390-5. PubMed ID: 12702978
[TBL] [Abstract][Full Text] [Related]
10. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.
Gardiner SJ; Gearry RB; Burt MJ; Chalmers-Watson T; Chapman BA; Ross AG; Stedman CA; Huelsen A; Barclay ML
J Gastroenterol Hepatol; 2011 Jan; 26(1):49-54. PubMed ID: 21175793
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat as a novel option to optimize thiopurines' metabolism in patients with inadequate metabolite levels.
Doré M; Frenette AJ; Mansour AM; Troyanov Y; Bégin J
Ann Pharmacother; 2014 May; 48(5):648-51. PubMed ID: 24523395
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
15. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.
Nguyen TV; Vu DH; Nguyen TM; Lachaux A; Boulieu R
Ther Drug Monit; 2013 Apr; 35(2):251-7. PubMed ID: 23503453
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.
Derijks LJ; Gilissen LP; Engels LG; Bos LP; Bus PJ; Lohman JJ; Curvers WL; Van Deventer SJ; Hommes DW; Hooymans PM
Ther Drug Monit; 2004 Jun; 26(3):311-8. PubMed ID: 15167634
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol: a useful adjunct to thiopurine therapy for pediatric ulcerative colitis in the biologic era.
Ihekweazu FD; Kellermayer R
J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):22-4. PubMed ID: 24590210
[TBL] [Abstract][Full Text] [Related]
18. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
Gao X; Zhang FB; Ding L; Liu H; Wang XD; Chen BL; Bi HC; Xiao YL; Zhao LZ; Chen MH; Huang M; Hu PJ
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):958-64. PubMed ID: 22664938
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease.
Kopylov U; Amre D; Theoret Y; Deslandres C; Seidman EG
J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):511-5. PubMed ID: 24918978
[TBL] [Abstract][Full Text] [Related]
20. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine.
Chrzanowska M; Krzymański M
Ther Drug Monit; 1999 Apr; 21(2):231-7. PubMed ID: 10217345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
